Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Burak Bilgin, Mehmet A.N. Sendur, Didem Şener Dede, Muhammed Bülent Akıncı & Bülent Yalçın. (2017) A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer. Current Medical Research and Opinion 33:9, pages 1559-1569.
Read now
Read now
Articles from other publishers (17)
Qian Zhong, Xina Xiao, Yijie Qiu, Zhiqiang Xu, Chunyu Chen, Baochen Chong, Xinjun Zhao, Shan Hai, Shuangqing Li, Zhenmei An & Lunzhi Dai. (2023) Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm 4:3.
Crossref
Crossref
Yang Luo, Yue Zhang, Yu‐Xin Wu, Han‐Bing Li, Di Shen & Yi‐Qun Che. (2021) Development of a novel five‐lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer. Journal of Clinical Laboratory Analysis 36:1.
Crossref
Crossref
Xīn Gào, Yan Zhang, Barbara Burwinkel, Yang Xuan, Bernd Holleczek, Hermann Brenner & Ben Schöttker. (2019) The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study. Clinical Epigenetics 11:1.
Crossref
Crossref
Dong Mei, Binlong Chen, Bing He, Haibin Liu, Zhiqiang Lin, Jialiang Lin, Xiaoyan Zhang, Ning Sun, Libo Zhao, Xiaoling Wang & Qiang Zhang. (2019) Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer. Acta Pharmaceutica Sinica B 9:5, pages 1061-1077.
Crossref
Crossref
Hannah Walters & Lynne Cox. (2018) mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases. International Journal of Molecular Sciences 19:8, pages 2325.
Crossref
Crossref
Liyan Du, Xiaomei Li, Linhong Zhen, Weiling Chen, Lingguang Mu, Yang Zhang & Ailin Song. (2018) Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Eun Young Lee, Eun-Yeung Gong, Jae-Sik Shin, Jai-Hee Moon, Hyun Jae Shim, Seung-Mi Kim, Seul Lee, Joonyee Jeong, Ji Hee Gong, Mi Jin Kim, Dae Hee Lee, Yoon Sun Park, Jimin Shin, Seung-Woo Hong, Yeong Seok Kim & Dong-Hoon Jin. (2018) Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin. Toxicology in Vitro 46, pages 229-236.
Crossref
Crossref
Kadri Altundag. (2017) Does tacrolimus have any positive impact on outcome of post-transplant breast cancer patients?. Breast Cancer Research and Treatment 168:1, pages 283-283.
Crossref
Crossref
Karen Lisa Smith & Vered Stearns. 2018. The Breast. The Breast
736
751.e4
.
Dorota Ciołczyk-Wierzbicka, Dorota Gil & Piotr Laidler. (2017) Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitors. Medical Oncology 35:1.
Crossref
Crossref
Elpetra P. M. Timmermans-Sprang, Ana Gracanin & Jan A. Mol. (2015) High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression. BMC Cancer 15:1.
Crossref
Crossref
Vin Cci Ng, Jeremy J Johnson & Sandra Cuellar. (2014) Targeting the mammalian target of rapamycin pathway with everolimus: Implications for the management of metastatic breast cancer. Journal of Oncology Pharmacy Practice 21:6, pages 433-442.
Crossref
Crossref
Uttara Saran, Michelangelo Foti & Jean-François Dufour. (2015) Cellular and molecular effects of the mTOR inhibitor everolimus. Clinical Science 129:10, pages 895-914.
Crossref
Crossref
James A. McCubrey, Stephen L. Abrams, Timothy L. Fitzgerald, Lucio Cocco, Alberto M. Martelli, Giuseppe Montalto, Melchiorre Cervello, Aurora Scalisi, Saverio Candido, Massimo Libra & Linda S. Steelman. (2015) Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis. Advances in Biological Regulation 57, pages 75-101.
Crossref
Crossref
James A. McCubrey, Nicole M. Davis, Stephen L. Abrams, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Antonino B. D'Assoro, Lucio Cocco, Alberto M. Martelli & Linda S. Steelman. (2014) Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. Advances in Biological Regulation 56, pages 81-107.
Crossref
Crossref
Nicole M. Davis, Melissa Sokolosky, Kristin Stadelman, Stephen L. Abrams, Massimo Libra, Saverio Candido, Ferdinando Nicoletti, Jerry Polesel, Roberta Maestro, Antonino D’Assoro, Lyudmyla Drobot, Dariusz Rakus, Agnieszka Gizak, Piotr Laidler, Joanna Dulińska-Litewka, Joerg Basecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Giuseppe Montalto, Melchiorre Cervello, Timothy L. Fitzgerald, Zoya N. Demidenko, Alberto M. Martelli, Lucio Cocco, Linda S. Steelman & James A. McCubrey. (2014) Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. Oncotarget 5:13, pages 4603-4650.
Crossref
Crossref
Yoshinori Tsukumo, Mathieu Laplante, Armen Parsyan, Davide Ruggero & Bruno Fonseca. 2014. Translation and Its Regulation in Cancer Biology and Medicine. Translation and Its Regulation in Cancer Biology and Medicine
307
343
.